Revolutionizing Clinical Trials with Suvoda's ePatient App
Key Takeaways
- ePatient aims to streamline clinical trial processes.
- The app integrates seamlessly with other Suvoda products.
- ePatient is available for early adopters and will be widely available by 2025.
Did You Know?
Introduction to Suvoda's ePatient
Suvoda LLC, known for its advancements in clinical trial technology focusing on areas such as oncology, central nervous system (CNS), and rare diseases, has announced the launch of their innovative ePatient product. The aim is to enhance the patient experience during clinical trials, simplifying aspects such as stipend and reimbursement payments as well as appointment management.
Streamlining Patient-Centric Features
The ePatient app is designed to gather various elements of the clinical trial process into a single, easy-to-use mobile interface. Key features include unified payments, appointments, reminders, and eCOA questionnaires. This offers a seamless experience for patients and integrates smoothly with existing Suvoda products like its Interactive Response Technology (IRT) and eConsent.
Improving Patient Experience
One of the main benefits of the ePatient app is the way it addresses patient needs during clinical trials. By listening to their customers, Suvoda has crafted a solution aimed at reducing the frustrations associated with participation, thereby elevating the overall patient experience. According to Suvoda's Senior Product Manager Elizabeth Morris, this innovation promises to ease the journey for patients significantly.
Key Benefits of ePatient
ePatient is expected to deliver four primary benefits that include reducing complexities, improving efficiency, and offering a cohesive user experience among others. CEO Jagath Wanninayake emphasizes the importance of this tool, particularly during vulnerable phases of a patient’s life, saying it is a step forward in achieving Suvoda's mission of simplifying clinical trials.
Phased Rollout and Availability
The app's rollout will occur in phases, initially focusing on patient payments, followed by the incorporation of appointment scheduling and reminders. Suvoda aims to make the app available on both iOS and Android devices. As of June 2024, a select group of early adopters will have access, with broader availability expected by 2025.
Global Expertise of Suvoda
Founded in 2013, Suvoda has made significant strides in clinical trial technology. The company is headquartered near Philadelphia but has offices in places like Portland, Barcelona, Bucharest, Iasi, and Tokyo. Known for its high Net Promoter Score, Suvoda supports over 1,400 trials in 85 countries, making it a recognized name in the industry.
Conclusion
Suvoda's introduction of the ePatient app marks a significant milestone in clinical trial management. Its primary goal is to ease the complex journey often faced by patients and enhance the operational efficiency for healthcare providers. By bringing various trial components under one easy-to-navigate platform, the app stands to benefit all stakeholders.
References
- Suvoda Official Websitehttps://www.suvoda.com/
- Clinical Trials in Oncologyhttps://www.cancer.gov/about-cancer/treatment/clinical-trials
- How Technology is Shaping Clinical Trialshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029939/